Permanent Forum on International Pharmaceutical Crime: Protecting public health globally
The Permanent Forum on International Pharmaceutical Crime (PFIPC) is an international enforcement forum aimed at protecting public health through the exchange of information and ideas to foster mutual cooperation.
Learn MoreOur Mission
Our mission is to foster international cooperation in the fight against pharmaceutical crime. We strive to protect public health by sharing knowledge, resources, and best practices among enforcement agencies worldwide.
Learn more about our initiatives, the work we do, and how we are making a difference globally. Stay informed about our latest efforts to combat counterfeit and illegal pharmaceuticals.
Gilead Sciences’ victim impact statement, USA v Patrick Boyd and Charles Boyd, March 2026
United States District Court Southern District of Florida USA v Patrick Boyd and Charles Boyd Gilead Sciences' Victim Impact Statement Filed March 9, 2026 Read the document.
Government sentencing memo, USA v Patrick Boyd and Charles Boyd, March 2026
United States District Court Southern District of Florida USA v Patrick Boyd and Charles Boyd Sentencing memo and response to defendants’ objections to pre-sentence investigation reports Filed March 11, 2026 Read the document.
March 10, 2026: Fake cancer drug distributor sentenced to almost four years in federal prison
Sanjay Kumar got 43 months for selling counterfeit Keytruda. PSM wrote federal agencies about a Super Bowl ad promoting diagnostic tests and compounded medicines with false claims.
PSM asks federal agencies to review Hims & Hers’ 2026 Super Bowl ad
On March 10, PSM sent letters to the FDA, FTC, and the Department of Justice asking them to take immediate action to address the ad's false and misleading promotion of its compounded programs and diagnostic tests.
Get Involved
Join us in our mission to protect public health. Learn more about how you can contribute to our efforts or collaborate with us. Your support and involvement are crucial to our success.
Contact Us